NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

Frontline Gastroenterology ◽

10.1136/fg.2010.001545 ◽

2010 ◽

Vol 1 (3) ◽

pp. 144-146 ◽

Author(s):

T. Orchard

Keyword(s):

Inflammatory Bowel Disease ◽

Crohn’S Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Nice Guidance ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Disease Community

Download Full-text

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2009.04112.x ◽

2010 ◽

Vol 31 (1) ◽

pp. 20-34 ◽

Author(s):

M. J. SHALE ◽

C. H. SEOW ◽

C. S. COFFIN ◽

G. G. KAPLAN ◽

R. PANACCIONE ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Viral Infection ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Review Article ◽

Chronic Viral Infection ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy

European Journal of Gastroenterology & Hepatology ◽

10.1097/meg.0000000000001917 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Gaurav B. Nigam ◽

Anirudh P. Bhandare ◽

George A. Antoniou ◽

Jimmy K. Limdi

Keyword(s):

Systematic Review ◽

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Meta Analysis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05082.x ◽

2012 ◽

Vol 35 (10) ◽

pp. 1175-1180 ◽

Author(s):

A. Buisson ◽

J.-F. Cuny ◽

A. Barbaud ◽

J.-L. Schmutz ◽

M.-A. Bigard ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients

Internal Medicine Journal ◽

10.1111/imj.13637 ◽

2017 ◽

Vol 47 (12) ◽

pp. 1445-1448 ◽

Author(s):

Faseeha C. Peer ◽

Andrew Miller ◽

Paul Pavli ◽

Kavitha Subramaniam

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease

British Medical Bulletin ◽

10.1093/bmb/ldp036 ◽

2009 ◽

Vol 92 (1) ◽

pp. 61-77 ◽

Author(s):

M. J. Shale

Keyword(s):

Inflammatory Bowel Disease ◽

Viral Infection ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

P584. Relapse risk and predictors for relapse in a real-life cohort of inflammatory bowel disease patients after discontinuation of anti-tumour necrosis factor therapy

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.703 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S397.1-S397

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Real Life ◽

Relapse Risk ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2011.04866.x ◽

2011 ◽

Vol 34 (11-12) ◽

pp. 1318-1327 ◽

Author(s):

G. Cullen ◽

D. Kroshinsky ◽

A. S. Cheifetz ◽

J. R. Korzenik

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

P422. Risks and clinical features of active tuberculosis developed in patients with inflammatory bowel disease receiving anti-tumour necrosis factor therapy

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.541 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S311.2-S311

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Clinical Features ◽

Bowel Disease ◽

Tumour Necrosis ◽

Active Tuberculosis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.14842 ◽

2018 ◽

Vol 48 (3) ◽

pp. 340-346 ◽

Author(s):

K. T. Park ◽

L. Sceats ◽

M. Dehghan ◽

A. W. Trickey ◽

A. Wren ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Propensity Score ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Surgical Site Infections ◽

Propensity Score Matching Analysis ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia

Internal Medicine Journal ◽

10.1111/j.1445-5994.2009.02122.x ◽

2010 ◽

Vol 40 (2) ◽

pp. 139-149 ◽

Author(s):

W. Connell ◽

J. M. Andrews ◽

S. Brown ◽

M. Sparrow

Keyword(s):

Inflammatory Bowel Disease ◽

Tumour Necrosis Factor ◽

Bowel Disease ◽

Tumour Necrosis ◽

Practical Guidelines ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text